Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket

By Avi Kapoor

Shares of Icosavax, Inc. (NASDAQ: ICVX ) rose sharply in pre-market trading after AstraZeneca announced plans to buy Icosavax in a deal valued at up to $1.1 billion.

Icosavax also reported topline interim Phase 2 results for combination VLP vaccine candidate IVX-A12 ag

You are viewing a robot-friendly page.Click hereto reload in standard format.